Clinical & Pharma

Experts Denounce Trump's Order to Separate MMR Vaccines
Clinical & Pharma Experts Denounce Trump's Order to Separate MMR Vaccines

Established scientific evidence is being replaced by political intuition, leading to what many experts describe as a "war on public health" that threatens the nation's youngest citizens. This shift manifested recently through a controversial executive directive requiring the dismantling of the

Is Federal Policy Undermining Local Harm Reduction Efforts?
Clinical & Pharma Is Federal Policy Undermining Local Harm Reduction Efforts?

James Maitland is a prominent figure in the field of public health and medical technology, recognized for his commitment to integrating data-driven solutions with grassroots community care. With a background in robotics and IoT applications, Maitland brings a unique perspective to how simple,

Why Is Cyclosporiasis Spiking in Our Food Supply Chain?
Clinical & Pharma Why Is Cyclosporiasis Spiking in Our Food Supply Chain?

The recent surge in reported cases of cyclosporiasis across North American metropolitan areas serves as a stark reminder that modern food safety protocols often fail to catch the most resilient biological threats before they reach the consumer's plate. In Quebec alone, health officials documented a

Advanced Humanized Models De-risk Neurology Drug Development
Clinical & Pharma Advanced Humanized Models De-risk Neurology Drug Development

The persistent gap between laboratory discovery and clinical application in Central Nervous System disorders continues to impose a massive financial and humanitarian burden on the global healthcare infrastructure. While fields such as oncology have witnessed a transformative era of precision

New Framework Exposes Critical Gaps in Medical AI Regulation
Clinical & Pharma New Framework Exposes Critical Gaps in Medical AI Regulation

The recent publication of the July 2026 Nature Medicine framework entitled Toward a Test of Medical AI Superintelligence has cast a glaring light on the widening chasm between rapid technological adoption and the lagging regulatory frameworks intended to safeguard patient welfare. While

Is D.C. Using Opioid Settlement Funds to Fill Budget Gaps?
Clinical & Pharma Is D.C. Using Opioid Settlement Funds to Fill Budget Gaps?

As a specialist in public health policy with a focus on fiscal accountability, I have spent decades analyzing how government budgets reflect a society’s true priorities. The current situation in Washington, D.C., serves as a cautionary tale of what happens when the desperate need for addiction

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later